2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile

C26H20N6O — CID 146522922

IUPAC2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile
SMILESCc1ccc2c(Nc3cccc(C(C)(C)C#N)c3)noc2c1C#Cc1cnc2cccnn12
InChIInChI=1S/C26H20N6O/c1-17-9-11-22-24(21(17)12-10-20-15-28-23-8-5-13-29-32(20)23)33-31-25(22)30-19-7-4-6-18(14-19)26(2,3)16-27/h4-9,11,13-15H,1-3H3,(H,30,31)
InChIKeyOJVYLWAQORQUCF-UHFFFAOYSA-N
MW432.49 g/mol
LogP5.12
Rot. Bonds3

About 2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile

2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile (PubChem CID 146522922) has the molecular formula C26H20N6O and a molecular weight of 432.49 g/mol. Its IUPAC name is 2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile.

Molecular Properties

Compound Name2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile
PubChem CID146522922
Molecular FormulaC26H20N6O
Molecular Weight432.49 g/mol
Exact Mass432.17
IUPAC Name2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile
SMILESCc1ccc2c(Nc3cccc(C(C)(C)C#N)c3)noc2c1C#Cc1cnc2cccnn12
InChIInChI=1S/C26H20N6O/c1-17-9-11-22-24(21(17)12-10-20-15-28-23-8-5-13-29-32(20)23)33-31-25(22)30-19-7-4-6-18(14-19)26(2,3)16-27/h4-9,11,13-15H,1-3H3,(H,30,31)
InChIKeyOJVYLWAQORQUCF-UHFFFAOYSA-N
XLogP5.12
TPSA92.04 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds3
Heavy Atoms33
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500432.49
LogP ≤ 55.12
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile?
The IUPAC name of 2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile (CID 146522922) is 2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile.
What is the SMILES notation for 2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile?
The canonical SMILES for 2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile is Cc1ccc2c(Nc3cccc(C(C)(C)C#N)c3)noc2c1C#Cc1cnc2cccnn12.
What is the InChIKey of 2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile?
The InChIKey is OJVYLWAQORQUCF-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H20N6O/c1-17-9-11-22-24(21(17)12-10-20-15-28-23-8-5-13-29-32(20)23)33-31-25(22)30-19-7-4-6-18(14-19)26(2,3)16-27/h4-9,11,13-15H,1-3H3,(H,30,31).
What are the key properties of 2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile?
2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile has a molecular weight of 432.49 g/mol, XLogP of 5.12, 3 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[[7-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-6-methyl-1,2-benzoxazol-3-yl]amino]phenyl]-2-methylpropanenitrile is sourced from PubChem (CID 146522922), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).